CTDC - China Technology Development Group Corporation - 2000 % in 3 Jahren - 500 Beiträge pro Seite
eröffnet am 04.10.06 23:06:38 von
neuester Beitrag 13.11.06 22:30:45 von
neuester Beitrag 13.11.06 22:30:45 von
Beiträge: 4
ID: 1.085.789
ID: 1.085.789
Aufrufe heute: 0
Gesamt: 691
Gesamt: 691
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 24 Minuten | 1697 | |
gestern 23:06 | 1306 | |
vor 39 Minuten | 1019 | |
gestern 12:46 | 824 | |
gestern 21:02 | 752 | |
vor 22 Minuten | 729 | |
vor 22 Minuten | 711 | |
vor 7 Minuten | 686 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 17.654,10 | -0,56 | 189 | |||
2. | 2. | 137,70 | -2,16 | 114 | |||
3. | 7. | 6,5840 | -2,14 | 74 | |||
4. | 3. | 6,8400 | -2,29 | 72 | |||
5. | 5. | 0,1775 | -3,79 | 66 | |||
6. | 8. | 3,7600 | +0,53 | 56 | |||
7. | 6. | 6,6820 | +0,75 | 56 | |||
8. | 4. | 2.383,46 | +0,17 | 55 |
Ich bin heute auf einen Nasdaq-Wert gestoßen, der in den letzten Tagen förmlich explodiert ist. In den einschlägigen Foren ist bis jetzt überhaupt nichts zu finden - deshalb meine Motivation.
Hier erst mal der Chart:
Was ich bisher erfahren konnte:
Es handelt sich um ein Unternehmen mit Sitz in Hongkong - sie machen in 'Nahrungsmittelzusatz und nutraceutical (Naturheilverfahren ??? und Netzsicherheits-Lösungen.
Die Marktkapitapitalisierung ist bei etwa 55 Mio $ und das KGV bei etwa 18.
Charttechnisch ist lt. aktueller Meldung ein Widerstand überwunden und ein neues 5 Monatshoch gebildet:
China Development Group Has Risen To Nearly A 5-Month High
(RTTNews) - China Development Group (CTDC) gapped up Wednesday and has climbed above the morning's range in the last 10 minutes. The stock is now up 1.24 at $6.03 on above average volume.
China Development Group has risen above resistance, to set nearly a 5-month high.
Die Aktie wird meines Wissens in Deutschland (noch) nicht gehandelt - Nasdaq sollte aber kein Problem sein. Heute übrigens unter den größten Gewinnern dort.
Hier erst mal der Chart:
Was ich bisher erfahren konnte:
Es handelt sich um ein Unternehmen mit Sitz in Hongkong - sie machen in 'Nahrungsmittelzusatz und nutraceutical (Naturheilverfahren ??? und Netzsicherheits-Lösungen.
Die Marktkapitapitalisierung ist bei etwa 55 Mio $ und das KGV bei etwa 18.
Charttechnisch ist lt. aktueller Meldung ein Widerstand überwunden und ein neues 5 Monatshoch gebildet:
China Development Group Has Risen To Nearly A 5-Month High
(RTTNews) - China Development Group (CTDC) gapped up Wednesday and has climbed above the morning's range in the last 10 minutes. The stock is now up 1.24 at $6.03 on above average volume.
China Development Group has risen above resistance, to set nearly a 5-month high.
Die Aktie wird meines Wissens in Deutschland (noch) nicht gehandelt - Nasdaq sollte aber kein Problem sein. Heute übrigens unter den größten Gewinnern dort.
Heute Zahlen bekanntgegeben - Verlust ausgeweitet - und das Ding steigt fürchtelich
Tagesgewinner an der NASDAQ !!!!!??????
China Technology Development Group Corporation $ 6.8233 1.47 27.46% 1,946,547
Oct 6, 2006 | 11:32AM
US Market Open NASDAQ 2300.1 -6.24 -0.27% | DJIA 11848.12 -17.45 -0.15% | S&P 1347.25 -5.97 -0.44%
Home › E-mail this page to a friend
Buy stock for just $4!
No account minimum
No investment minimum
No inactivity fees
www.sharebuilder.com
News
Back to Headlines | Previous Story | Next Story
China Technology Development Group Corporation Financial Results Announcement for the Six Months Ended June 30, 2006 (Unaudited)
HONG KONG, Oct. 6 /Xinhua-PRNewswire-FirstCall/ -- China Technology Development Group Corporation (Nasdaq: CTDC) (collectively, the "Company", "We", "us", or "our") announced today its unaudited consolidated financial results for the six month period ended June 30, 2006.
Our revenues increased by US$165,000, or 39.66%, from US$416,000 in the six months ended June 30, 2005 (the "2005 Period") to US$581,000 in the the six months ended June 30, 2006 (the "2006 Period"). The nutraceutical business acquired in 2005 contributed a total revenue of US$203,000 in the 2006 Period. Excluding this, the revenues of our IT operations slightly decreased by US$38,000, or 9.13% from US$416,000 in the 2005 Period to US$378,000 in the 2006 Period.
Our total cost of sales increased by US$96,000, or 45.5%, from US$211,000 in the 2005 Period to US$307,000 in the 2006 Period. The cost of sales of our nutraceutical business in the 2006 Period was US$150,000. Excluding this, the cost of sales of our IT operations in the 2006 Period amounted to US$157,000, which represented a decrease of US$54,000, or 25.59%, from US$211,000 in the 2005 Period. The decrease was due primarily to an increase in the proportion of sales of our self-developed products, the costs of which are lower than the cost of products purchased from other suppliers due to the increased control we have with respect to the cost of the materials utilized to produce such products.
As a result, our gross profit in the 2006 Period amounted to US$274,000, which increased by US$69,000, or 33.66%, from US$205,000 in the 2005 Period. The gross profit of our nutraceutical business in the 2006 Period amounted to US$53,000. Excluding this, the gross profit of our IT operations in the 2006 Period amounted to US$221,000, which represented an increase of US$16,000, or 7.8% from US$205,000 in the 2005 Period. As a percentage of sales, the gross profit margin of our IT operations increased by 9.19%, from 49.28% in the 2005 Period to 58.47% in the 2006 Period.
Selling, general and administrative expenses ("SG&A expenses") increased by US$627,000, or 125.9%, from US$498,000 in the 2005 Period to US$1,125,000 in the 2006 Period. SG&A of our nutraceutical operations in the 2006 Period amounted to US$308,000 which mainly included amortization and depreciation charges of approximately US$158,300 for the 2006 Period. Excluding this, the SG&A expenses of our IT operations and corporate office increased by US$319,000, or 64.06%, from US$498,000 of the 2005 Period to US$817,000 of the 2006 Period.
The significant increase in the SG&A expense was due to the following factors:
(1) SG&A expenses of our IT operations increased by US$56,000
or 15.56%, from US$360,000 in the 2005 Period to
US$416,000 in the 2006 Period, due primarily to additional
technicians that were recruited by us to develop new
products;
(2) SG&A expenses of our corporate office increased by
US$263,000, or 190.58%, from US$138,000 in the 2005 Period to
US$401,000 in the 2006 Period. The significant increase
was due primarily to an increase in staff costs and rental
expenses as a result of the expansion of our corporate office
beginning in May 2005.
As of June 30, 2006, we had a cash balance of US$878,000. The Company also maintained a deposit of US$783,000 with China Biotech Holdings Limited, a related company, for the purpose of financing potential investments in nutraceutical entities in China. We also had available cash equivalents of $273,000 in the form of accounts receivables due from Beijing Holdings Limited, our principal stockholder, which amounts represented the proceeds receivable from Beijing Holdings Limited in respect of the sale of available- for-sales securities owned by us to Beijing Holdings Limited.
CHINA TECHNOLOGY DEVELOPMENT GROUP CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except per share data)
For the periods ended June 30, 2005 and 2006
June, 30 June 30,
2005 2006
US$(Note (1)) US$(Note (1))
Continuing operations:
Revenues 416 581
Cost of sales (211) (307)
Gross Profit 205 274
Selling, general and administrative expenses (498) (1,125)
Operating loss (293) (851)
Interest income -- 5
Non-operating income 39 76
Non-operating expenses -- (35)
Loss before income tax provision (254) (805)
Income taxes provision -- (1)
Loss from continuing operations before
minority interests (254) (806)
Minority interest-continuing operations -- 70
Loss from continuing operations (254) (736)
Discontinued operations:
Loss from discontinued operations including
loss on disposal of US$63 on March 31, 2005 (36) --
Net loss for the period (290) (736)
Loss per share
-Basic and dilutive (0.04) (0.07)
Loss per share from continuing operations
-Basic and dilutive (0.03) (0.07)
Income/(loss) per share from discontinued
operations
-Basic and dilutive (0.01) --
Weighted average ordinary shares
-Basic and dilutive 6,894 11,275
CHINA TECHNOLOGY DEVELOPMENT GROUP CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
at December 31, 2005 and June 30,2006
December 31, June 30,
2005 2006
US$(Note (1)) US$(Note (1))
ASSETS
CURRENT ASSETS
Cash and cash equivalents 2,292 878
Short-term investments-security trust
account 14 1
Available-for-sale securities 46 55
Trade accounts receivable, net 99 92
Inventories 323 380
Value added tax and business tax
recoverable -- 13
Due from related parties 1,057 1,106
Prepayment for investment in subsidiary -- 75
Other assets 183 148
TOTAL CURRENT ASSETS 4,014 2,748
Long-term prepayment for rental of land 66 65
Property, plant and equipment, net 1,147 1,058
Intangible asset 818 737
Goodwill 8,697 8,697
TOTAL ASSETS 14,742 13,305
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Trade accounts payable 72 72
Accrued professional fees 484 313
Income tax payable 31 30
Value added tax and business tax payable 5 --
Deferred government grants 29 12
Due to a related party 446 62
Short term borrowings 111 71
Deferred tax liabilities 62 62
Other liabilities and accrued expenses 465 460
TOTAL CURRENT LIABILITIES 1,705 1,082
Minority interests 690 619
SHAREHOLDERS' EQUITY
Common stock, US$0.01 par value; 2,500,000,000 shares
authorised;
shares issued and outstanding 11,274,497
in 2005 and 2006) 114 114
Additional paid-in capital 33,765 33,765
Accumulated deficit (21,412) (22,148)
Accumulated other comprehensive losses (120) (127)
TOTAL SHAREHOLDERS' EQUITY 12,347 11,604
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 14,742 13,305
CHINA TECHNOLOGY DEVELOPMENT GROUP CORPORATION
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amount in thousands)
For the periods ended June 30, 2005 and 2006
2005 2006
US$(Note (1)) US$(Note (1))
Cash flows from operating activities
Net loss (331) (736)
Adjustments to reconcile net loss to net
cash used in operating activities
Minority interests in loss of consolidated
subsidiaries -- (71)
Amortization of intangible asset, goodwill
and software development costs -- 81
Amortization of long-term prepayment for
rental of land -- 1
Depreciation 6 95
Dividend income -- (1)
Unrealised loss on trading securities 41 --
Gain on disposal of available-for-sale
securities (2) --
Loss on disposal of discontinued
operations 63 --
Changes in assets and liabilities:
Decrease in trade accounts receivable 69 7
Increase in inventories (8) (57)
(Increase)/decrease in due from related
parties and other assets 8 (14)
Decrease in trade accounts payable, amount
due to a related party and other current
liabilities (156) (577)
Decrease in income tax payable (2) (19)
Net cash used in operating activities (312) (1,291)
Cash flows from investing activities
Security trust account 1,929 13
Dividend income -- 1
Decrease in funds held by related parties
for security investment purposes 1,034 --
Net cash and cash equivalents disposal of
upon disposal of discontinued operations (44) --
Proceeds from disposal of
available-for-sale securities 222 --
Prepayment for investment in subsidiary -- (75)
Purchase of property, plant and equipment -- (6)
Proceed on disposal of fixed assets (6) --
Net cash provided by investing activities 3,135 (67)
Cash flows from financing activities
Repayment of short term borrowings -- (40)
Net cash used in financing activities -- (40)
Effect of exchange rate changes on cash and
cash equivalents 1 (16)
Net increase/ (decrease) in cash and cash
equivalents 2,824 (1,414)
Cash and cash equivalents at beginning of
period 657 2,292
Cash and cash equivalents at end of period 3,481 878
CHINA TECHNOLOGY DEVELOPMENT GROUP CORPORATION
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(Amounts in thousands)
at June 30, 2005, December 31, 2005 and June 30, 2006
Stock
No. of Options
shares Equity Granted
US$(Note (1)) US$(Note (1))
Balance at June 30, 2005 6,894,497 23,483 --
Issue of shares 4,380,000 9,998 --
Stock options granted -- 398
Net loss -- --
Net unrealized gain on
available-for-sale
securities -- --
Less: Reclassification
adjustment for loss
realized on sale -- --
Translation adjustment -- --
Total comprehensive loss for the
year
Balance at December 31, 2005 11,274,497 33,481 398
Net loss -- --
Net unrealized gain on
available-for-sale securities -- --
Translation adjustment -- --
Total comprehensive loss for the
year
Balance at June 30, 2006 11,274,497 33,481 398
Accumulated
other Total
Accumulated comprehensive shareholders'
losses losses equity
US$(Note (1)) US$(Note (1)) US$(Note (1))
Balance at June 30, 2005 (19,259) (444) 3,780
Issue of shares -- -- 9,998
Stock options granted -- -- 398
Net loss (2,153) - (2,153)
Net unrealized gain on
available-for-sale securities -- 23 23
Less: Reclassification
adjustment for loss
realized on sale -- 362 362
Translation adjustment -- (61) (61)
Total comprehensive loss for
the year 324
Balance at December 31, 2005 (21,412) (120) 12,347
Net loss (736) (736)
--
Net unrealized gain on
available-for-sale securities -- 9 9
Translation adjustment -- (16) (16)
Total comprehensive loss for
the year (7)
Balance at June 30, 2006 (22,148) (127) 11,604
Note (1): The functional currency of the Company is Renminbi ("Rmb"),
the lawful currency of the People's Republic of China. For the
convenience of the reader, translation of amounts from Renminbi
into United States Dollars ("US$") has been made at the noon
buying rate in New York City for cable transfer in foreign
currencies as certified for customs purposes by the Federal
Reserve Bank of New York City on June 30, 2006 of Rmb 7.9943 =
US$1.00 for the operating results of periods ended June 30, 2005
and 2006 and for the financial position as of December 31, 2005
and June 30, 2006. No representation is made that the Renminbi
amounts could have been, or could be, converted into United
States Dollars at that rate or at any other certain rate.
Note (2): Our results for the 2006 Period included the results of our IT
operations and nutraceutical operations (acquired in 2005), as
compared to solely the IT operations was included in the 2005
Period.
About CTDC
CTDC is engaged in providing information network security solutions and developing health food products utilizing bio-active components of bamboo in People's Republic of China. For more information, please visit our website at www.chinactdc.com .
This Report of Foreign Private Issuer on Form 6-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or the Company's future financial performance. The Company has attempted to identify forward-looking statements by terminology including "anticipates", "believes", "expects", "can", "continue", "could", "estimates", "expects", "intends", "may", "plans", "potential", "predict", "should" or "will" or the negative of these terms or other comparable terminology. These statements are only predictions, uncertainties and other factors may cause the Company's actual results, levels of activity, performance or achievements to be materially different from any future results, levels or activity, performance or achievements expressed or implied by these forward-looking statements. The information in this Report on Form 6-K is not intended to project future performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company does not guarantee future results, levels of activity, performance or achievements. The Company expectations are as of the date this Form 6-K is filed, and the Company does not intend to update any of the forward-looking statements after the date this Report on Form 6-K is filed to confirm these statements to actual results, unless required by law.
For Further information:
Michael Siu
Executive Director, Chief Financial Officer and Secretary
Tel: +852-3112-8461
Fax: +852-3112-8410
Email: michael.siu@chinactdc.com
SOURCE China Technology Development Group Corporation
Tagesgewinner an der NASDAQ !!!!!??????
China Technology Development Group Corporation $ 6.8233 1.47 27.46% 1,946,547
Oct 6, 2006 | 11:32AM
US Market Open NASDAQ 2300.1 -6.24 -0.27% | DJIA 11848.12 -17.45 -0.15% | S&P 1347.25 -5.97 -0.44%
Home › E-mail this page to a friend
Buy stock for just $4!
No account minimum
No investment minimum
No inactivity fees
www.sharebuilder.com
News
Back to Headlines | Previous Story | Next Story
China Technology Development Group Corporation Financial Results Announcement for the Six Months Ended June 30, 2006 (Unaudited)
HONG KONG, Oct. 6 /Xinhua-PRNewswire-FirstCall/ -- China Technology Development Group Corporation (Nasdaq: CTDC) (collectively, the "Company", "We", "us", or "our") announced today its unaudited consolidated financial results for the six month period ended June 30, 2006.
Our revenues increased by US$165,000, or 39.66%, from US$416,000 in the six months ended June 30, 2005 (the "2005 Period") to US$581,000 in the the six months ended June 30, 2006 (the "2006 Period"). The nutraceutical business acquired in 2005 contributed a total revenue of US$203,000 in the 2006 Period. Excluding this, the revenues of our IT operations slightly decreased by US$38,000, or 9.13% from US$416,000 in the 2005 Period to US$378,000 in the 2006 Period.
Our total cost of sales increased by US$96,000, or 45.5%, from US$211,000 in the 2005 Period to US$307,000 in the 2006 Period. The cost of sales of our nutraceutical business in the 2006 Period was US$150,000. Excluding this, the cost of sales of our IT operations in the 2006 Period amounted to US$157,000, which represented a decrease of US$54,000, or 25.59%, from US$211,000 in the 2005 Period. The decrease was due primarily to an increase in the proportion of sales of our self-developed products, the costs of which are lower than the cost of products purchased from other suppliers due to the increased control we have with respect to the cost of the materials utilized to produce such products.
As a result, our gross profit in the 2006 Period amounted to US$274,000, which increased by US$69,000, or 33.66%, from US$205,000 in the 2005 Period. The gross profit of our nutraceutical business in the 2006 Period amounted to US$53,000. Excluding this, the gross profit of our IT operations in the 2006 Period amounted to US$221,000, which represented an increase of US$16,000, or 7.8% from US$205,000 in the 2005 Period. As a percentage of sales, the gross profit margin of our IT operations increased by 9.19%, from 49.28% in the 2005 Period to 58.47% in the 2006 Period.
Selling, general and administrative expenses ("SG&A expenses") increased by US$627,000, or 125.9%, from US$498,000 in the 2005 Period to US$1,125,000 in the 2006 Period. SG&A of our nutraceutical operations in the 2006 Period amounted to US$308,000 which mainly included amortization and depreciation charges of approximately US$158,300 for the 2006 Period. Excluding this, the SG&A expenses of our IT operations and corporate office increased by US$319,000, or 64.06%, from US$498,000 of the 2005 Period to US$817,000 of the 2006 Period.
The significant increase in the SG&A expense was due to the following factors:
(1) SG&A expenses of our IT operations increased by US$56,000
or 15.56%, from US$360,000 in the 2005 Period to
US$416,000 in the 2006 Period, due primarily to additional
technicians that were recruited by us to develop new
products;
(2) SG&A expenses of our corporate office increased by
US$263,000, or 190.58%, from US$138,000 in the 2005 Period to
US$401,000 in the 2006 Period. The significant increase
was due primarily to an increase in staff costs and rental
expenses as a result of the expansion of our corporate office
beginning in May 2005.
As of June 30, 2006, we had a cash balance of US$878,000. The Company also maintained a deposit of US$783,000 with China Biotech Holdings Limited, a related company, for the purpose of financing potential investments in nutraceutical entities in China. We also had available cash equivalents of $273,000 in the form of accounts receivables due from Beijing Holdings Limited, our principal stockholder, which amounts represented the proceeds receivable from Beijing Holdings Limited in respect of the sale of available- for-sales securities owned by us to Beijing Holdings Limited.
CHINA TECHNOLOGY DEVELOPMENT GROUP CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except per share data)
For the periods ended June 30, 2005 and 2006
June, 30 June 30,
2005 2006
US$(Note (1)) US$(Note (1))
Continuing operations:
Revenues 416 581
Cost of sales (211) (307)
Gross Profit 205 274
Selling, general and administrative expenses (498) (1,125)
Operating loss (293) (851)
Interest income -- 5
Non-operating income 39 76
Non-operating expenses -- (35)
Loss before income tax provision (254) (805)
Income taxes provision -- (1)
Loss from continuing operations before
minority interests (254) (806)
Minority interest-continuing operations -- 70
Loss from continuing operations (254) (736)
Discontinued operations:
Loss from discontinued operations including
loss on disposal of US$63 on March 31, 2005 (36) --
Net loss for the period (290) (736)
Loss per share
-Basic and dilutive (0.04) (0.07)
Loss per share from continuing operations
-Basic and dilutive (0.03) (0.07)
Income/(loss) per share from discontinued
operations
-Basic and dilutive (0.01) --
Weighted average ordinary shares
-Basic and dilutive 6,894 11,275
CHINA TECHNOLOGY DEVELOPMENT GROUP CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
at December 31, 2005 and June 30,2006
December 31, June 30,
2005 2006
US$(Note (1)) US$(Note (1))
ASSETS
CURRENT ASSETS
Cash and cash equivalents 2,292 878
Short-term investments-security trust
account 14 1
Available-for-sale securities 46 55
Trade accounts receivable, net 99 92
Inventories 323 380
Value added tax and business tax
recoverable -- 13
Due from related parties 1,057 1,106
Prepayment for investment in subsidiary -- 75
Other assets 183 148
TOTAL CURRENT ASSETS 4,014 2,748
Long-term prepayment for rental of land 66 65
Property, plant and equipment, net 1,147 1,058
Intangible asset 818 737
Goodwill 8,697 8,697
TOTAL ASSETS 14,742 13,305
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Trade accounts payable 72 72
Accrued professional fees 484 313
Income tax payable 31 30
Value added tax and business tax payable 5 --
Deferred government grants 29 12
Due to a related party 446 62
Short term borrowings 111 71
Deferred tax liabilities 62 62
Other liabilities and accrued expenses 465 460
TOTAL CURRENT LIABILITIES 1,705 1,082
Minority interests 690 619
SHAREHOLDERS' EQUITY
Common stock, US$0.01 par value; 2,500,000,000 shares
authorised;
shares issued and outstanding 11,274,497
in 2005 and 2006) 114 114
Additional paid-in capital 33,765 33,765
Accumulated deficit (21,412) (22,148)
Accumulated other comprehensive losses (120) (127)
TOTAL SHAREHOLDERS' EQUITY 12,347 11,604
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 14,742 13,305
CHINA TECHNOLOGY DEVELOPMENT GROUP CORPORATION
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amount in thousands)
For the periods ended June 30, 2005 and 2006
2005 2006
US$(Note (1)) US$(Note (1))
Cash flows from operating activities
Net loss (331) (736)
Adjustments to reconcile net loss to net
cash used in operating activities
Minority interests in loss of consolidated
subsidiaries -- (71)
Amortization of intangible asset, goodwill
and software development costs -- 81
Amortization of long-term prepayment for
rental of land -- 1
Depreciation 6 95
Dividend income -- (1)
Unrealised loss on trading securities 41 --
Gain on disposal of available-for-sale
securities (2) --
Loss on disposal of discontinued
operations 63 --
Changes in assets and liabilities:
Decrease in trade accounts receivable 69 7
Increase in inventories (8) (57)
(Increase)/decrease in due from related
parties and other assets 8 (14)
Decrease in trade accounts payable, amount
due to a related party and other current
liabilities (156) (577)
Decrease in income tax payable (2) (19)
Net cash used in operating activities (312) (1,291)
Cash flows from investing activities
Security trust account 1,929 13
Dividend income -- 1
Decrease in funds held by related parties
for security investment purposes 1,034 --
Net cash and cash equivalents disposal of
upon disposal of discontinued operations (44) --
Proceeds from disposal of
available-for-sale securities 222 --
Prepayment for investment in subsidiary -- (75)
Purchase of property, plant and equipment -- (6)
Proceed on disposal of fixed assets (6) --
Net cash provided by investing activities 3,135 (67)
Cash flows from financing activities
Repayment of short term borrowings -- (40)
Net cash used in financing activities -- (40)
Effect of exchange rate changes on cash and
cash equivalents 1 (16)
Net increase/ (decrease) in cash and cash
equivalents 2,824 (1,414)
Cash and cash equivalents at beginning of
period 657 2,292
Cash and cash equivalents at end of period 3,481 878
CHINA TECHNOLOGY DEVELOPMENT GROUP CORPORATION
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(Amounts in thousands)
at June 30, 2005, December 31, 2005 and June 30, 2006
Stock
No. of Options
shares Equity Granted
US$(Note (1)) US$(Note (1))
Balance at June 30, 2005 6,894,497 23,483 --
Issue of shares 4,380,000 9,998 --
Stock options granted -- 398
Net loss -- --
Net unrealized gain on
available-for-sale
securities -- --
Less: Reclassification
adjustment for loss
realized on sale -- --
Translation adjustment -- --
Total comprehensive loss for the
year
Balance at December 31, 2005 11,274,497 33,481 398
Net loss -- --
Net unrealized gain on
available-for-sale securities -- --
Translation adjustment -- --
Total comprehensive loss for the
year
Balance at June 30, 2006 11,274,497 33,481 398
Accumulated
other Total
Accumulated comprehensive shareholders'
losses losses equity
US$(Note (1)) US$(Note (1)) US$(Note (1))
Balance at June 30, 2005 (19,259) (444) 3,780
Issue of shares -- -- 9,998
Stock options granted -- -- 398
Net loss (2,153) - (2,153)
Net unrealized gain on
available-for-sale securities -- 23 23
Less: Reclassification
adjustment for loss
realized on sale -- 362 362
Translation adjustment -- (61) (61)
Total comprehensive loss for
the year 324
Balance at December 31, 2005 (21,412) (120) 12,347
Net loss (736) (736)
--
Net unrealized gain on
available-for-sale securities -- 9 9
Translation adjustment -- (16) (16)
Total comprehensive loss for
the year (7)
Balance at June 30, 2006 (22,148) (127) 11,604
Note (1): The functional currency of the Company is Renminbi ("Rmb"),
the lawful currency of the People's Republic of China. For the
convenience of the reader, translation of amounts from Renminbi
into United States Dollars ("US$") has been made at the noon
buying rate in New York City for cable transfer in foreign
currencies as certified for customs purposes by the Federal
Reserve Bank of New York City on June 30, 2006 of Rmb 7.9943 =
US$1.00 for the operating results of periods ended June 30, 2005
and 2006 and for the financial position as of December 31, 2005
and June 30, 2006. No representation is made that the Renminbi
amounts could have been, or could be, converted into United
States Dollars at that rate or at any other certain rate.
Note (2): Our results for the 2006 Period included the results of our IT
operations and nutraceutical operations (acquired in 2005), as
compared to solely the IT operations was included in the 2005
Period.
About CTDC
CTDC is engaged in providing information network security solutions and developing health food products utilizing bio-active components of bamboo in People's Republic of China. For more information, please visit our website at www.chinactdc.com .
This Report of Foreign Private Issuer on Form 6-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or the Company's future financial performance. The Company has attempted to identify forward-looking statements by terminology including "anticipates", "believes", "expects", "can", "continue", "could", "estimates", "expects", "intends", "may", "plans", "potential", "predict", "should" or "will" or the negative of these terms or other comparable terminology. These statements are only predictions, uncertainties and other factors may cause the Company's actual results, levels of activity, performance or achievements to be materially different from any future results, levels or activity, performance or achievements expressed or implied by these forward-looking statements. The information in this Report on Form 6-K is not intended to project future performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company does not guarantee future results, levels of activity, performance or achievements. The Company expectations are as of the date this Form 6-K is filed, and the Company does not intend to update any of the forward-looking statements after the date this Report on Form 6-K is filed to confirm these statements to actual results, unless required by law.
For Further information:
Michael Siu
Executive Director, Chief Financial Officer and Secretary
Tel: +852-3112-8461
Fax: +852-3112-8410
Email: michael.siu@chinactdc.com
SOURCE China Technology Development Group Corporation
So - weiß zwar nicht, was mich geritten hat - aber beim dem Chart habe mir eine kleine Position aufgebaut.
Mal abwarten, was passiert
Einstand: 6,80
Mal abwarten, was passiert
Einstand: 6,80
Donnerwetter - schaue eben mal nach und staune:
Heute 26 % Plus und unter den Tagesgewinnern an der Nasdaq:
Heute 26 % Plus und unter den Tagesgewinnern an der Nasdaq:
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
189 | ||
114 | ||
74 | ||
72 | ||
66 | ||
56 | ||
56 | ||
55 | ||
45 | ||
43 |
Wertpapier | Beiträge | |
---|---|---|
32 | ||
31 | ||
27 | ||
26 | ||
26 | ||
26 | ||
24 | ||
22 | ||
20 | ||
20 |